The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Latest Articles

Published online 9 September 2002. doi:10.1084/jem.20020805
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 477K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clayton, E.
Right arrow Articles by Turner, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Clayton, E.
Right arrow Articles by Turner, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© Rockefeller University Press, 0022-1007
The Journal of Experimental Medicine

A Crucial Role for the p110{delta} Subunit of Phosphatidylinositol 3-Kinase in B Cell Development and Activation

Elizabeth Clayton1, Giuseppe Bardi1, Sarah E. Bell1, David Chantry2, C. Peter Downes3, Alexander Gray3, Lisa A. Humphries4, David Rawlings5,6, Helen Reynolds1, Elena Vigorito1 and Martin Turner5

1 Laboratory of Lymphocyte Signaling and Development, Molecular Immunology Programme, The Babraham Institute, Babraham, Cambridge CB2 4AT, United Kingdom
2 COS Corporation, Bothell, WA 98021
3 Department of Biochemistry, University of Dundee, Dundee, DD1 5EH, United Kingdom
4 The Molecular Biology Institute, University of California, Los Angeles, CA 90095
5 Department of Immunology, University of Washington, School of Medicine, Seattle, WA 98195
6 Department of Pediatrics, University of Washington, School of Medicine, Seattle, WA 98195

Address correspondence to M. Turner, Lymphocyte Signaling & Development Laboratory, Molecular Immunology Programme, Cambridge CB2 4AT, UK. Phone: 44-0-1223-496-460; Fax: 44-0-1223-496-023; E-mail: martin.turner{at}bbsrc.ac.uk

Mice lacking the p110{delta} catalytic subunit of phosphatidylinositol 3-kinase have reduced numbers of B1 and marginal zone B cells, reduced levels of serum immunoglobulins, respond poorly to immunization with type II thymus-independent antigen, and are defective in their primary and secondary responses to thymus-dependent antigen. p110{delta}-/- B cells proliferate poorly in response to B cell receptor (BCR) or CD40 signals in vitro, fail to activate protein kinase B, and are prone to apoptosis. p110{delta} function is required for BCR-mediated calcium flux, activation of phosphlipaseC{gamma}2, and Bruton's tyrosine kinase. Thus, p110{delta} plays a critical role in B cell homeostasis and function.

Key Words: Akt • Btk • calcium • gene targeting • p110{delta}


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search